Impedimed Ltd (IPD) - Cash Flow Conversion Efficiency

Latest as of December 2025: -1.053x

Based on the latest financial reports, Impedimed Ltd (IPD) has a cash flow conversion efficiency ratio of -1.053x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.50 Million ≈ $-6.72 Million USD) by net assets (AU$9.02 Million ≈ $6.38 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Impedimed Ltd - Cash Flow Conversion Efficiency Trend (2008–2025)

This chart illustrates how Impedimed Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read IPD liabilities breakdown for a breakdown of total debt and financial obligations.

Impedimed Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Impedimed Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Mico BioMed Co. Ltd. KQ:214610	-0.315x
Cherry AG XETRA:C3RY	0.023x
Bal Pharma Limited NSE:BALPHARMA	0.129x
Vesuvius PLC LSE:VSVS	0.022x
Bd Multimedia PA:ALBDM	0.061x
Regency Ceramics Limited NSE:REGENCERAM	0.230x
Stockwik Forvaltning AB ST:STWK	-0.096x
BioLineRx Ltd NASDAQ:BLRX	-0.108x

Annual Cash Flow Conversion Efficiency for Impedimed Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Impedimed Ltd from 2008 to 2025. For the full company profile with market capitalisation and key ratios, see market value of Impedimed Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-06-30	AU$20.50 Million ≈ $14.50 Million	AU$-14.64 Million ≈ $-10.36 Million	-0.715x	-63.65%
2024-06-30	AU$40.74 Million ≈ $28.83 Million	AU$-17.79 Million ≈ $-12.59 Million	-0.437x	-47.27%
2023-06-30	AU$60.88 Million ≈ $43.08 Million	AU$-18.05 Million ≈ $-12.77 Million	-0.296x	+3.39%
2022-06-30	AU$51.04 Million ≈ $36.12 Million	AU$-15.66 Million ≈ $-11.08 Million	-0.307x	+40.94%
2021-06-30	AU$25.51 Million ≈ $18.05 Million	AU$-13.26 Million ≈ $-9.38 Million	-0.520x	+26.02%
2020-06-30	AU$27.36 Million ≈ $19.36 Million	AU$-19.22 Million ≈ $-13.60 Million	-0.702x	+43.40%
2019-06-30	AU$15.79 Million ≈ $11.17 Million	AU$-19.59 Million ≈ $-13.86 Million	-1.241x	-89.40%
2018-06-30	AU$35.80 Million ≈ $25.33 Million	AU$-23.46 Million ≈ $-16.60 Million	-0.655x	-50.68%
2017-06-30	AU$58.80 Million ≈ $41.60 Million	AU$-25.57 Million ≈ $-18.09 Million	-0.435x	-65.33%
2016-06-30	AU$85.25 Million ≈ $60.32 Million	AU$-22.42 Million ≈ $-15.86 Million	-0.263x	+14.83%
2015-06-30	AU$34.84 Million ≈ $24.65 Million	AU$-10.76 Million ≈ $-7.61 Million	-0.309x	+38.57%
2014-06-30	AU$13.53 Million ≈ $9.57 Million	AU$-6.80 Million ≈ $-4.81 Million	-0.503x	+30.62%
2013-06-30	AU$10.59 Million ≈ $7.50 Million	AU$-7.67 Million ≈ $-5.43 Million	-0.724x	-6.30%
2012-06-30	AU$17.31 Million ≈ $12.25 Million	AU$-11.80 Million ≈ $-8.35 Million	-0.682x	-24.75%
2011-06-30	AU$20.68 Million ≈ $14.63 Million	AU$-11.30 Million ≈ $-7.99 Million	-0.546x	-16.93%
2010-06-30	AU$22.23 Million ≈ $15.73 Million	AU$-10.39 Million ≈ $-7.35 Million	-0.467x	+60.09%
2009-06-30	AU$10.07 Million ≈ $7.12 Million	AU$-11.79 Million ≈ $-8.34 Million	-1.171x	-94.18%
2008-06-30	AU$12.30 Million ≈ $8.70 Million	AU$-7.42 Million ≈ $-5.25 Million	-0.603x	--

About Impedimed Ltd

AU:IPD Australia Medical Devices

Market Cap

$12.98 Million

AU$18.35 Million AUD

Market Cap Rank

#26202 Global

#1247 in Australia

Share Price

AU$0.01

Change (1 day)

+0.00%

52-Week Range

AU$0.01 - AU$0.06

All Time High

AU$1.68